Published by Iain Gilbert on 19th October 2026
(Sharecast News) - Drugmaker GSK reported new early‑stage global data for risvutatug rezetecan (Ris‑Rez), an experimental cancer treatment being tested in patients with relapsed small‑cell lung cancer.
URL: http://www.digitallook.com/dl/news/story/36288150/...